27 results on '"Mehnert, Janice"'
Search Results
2. The “Great Debate” at Melanoma Bridge 2022, Naples, December 1st–3rd, 2022
3. Significant survival improvements for patients with melanoma brain metastases: can we reach cure in the current era?
4. A phase I study of veliparib with cyclophosphamide and veliparib combined with doxorubicin and cyclophosphamide in advanced malignancies
5. A phase Ib dose-escalation study of troriluzole (BHV-4157), an oral glutamatergic signaling modulator, in combination with nivolumab in patients with advanced solid tumors
6. The “Great Debate” at Melanoma Bridge 2021, December 2nd–4th, 2021
7. Evaluation of a Gene Expression Profiling Assay in Primary Cutaneous Melanoma
8. Continuous versus intermittent BRAF and MEK inhibition in patients with BRAF-mutated melanoma: a randomized phase 2 trial
9. Autophagy promotes growth of tumors with high mutational burden by inhibiting a T-cell immune response
10. A phase I study of AT-101, a BH3 mimetic, in combination with paclitaxel and carboplatin in solid tumors
11. Phase I neoadjuvant study of intravesical recombinant fowlpox-GM-CSF (rF-GM-CSF) or fowlpox-TRICOM (rF-TRICOM) in patients with bladder carcinoma
12. A phase I trial of MK-2206 and hydroxychloroquine in patients with advanced solid tumors
13. Patterns of response with talimogene laherparepvec in combination with ipilimumab or ipilimumab alone in metastatic unresectable melanoma
14. Early objective response to avelumab treatment is associated with improved overall survival in patients with metastatic Merkel cell carcinoma
15. Autophagy maintains tumour growth through circulating arginine
16. Publisher Correction: Autophagy promotes growth of tumors with high mutational burden by inhibiting a T-cell immune response
17. Avelumab in patients with previously treated metastatic melanoma: phase 1b results from the JAVELIN Solid Tumor trial
18. Safety and enhanced immunostimulatory activity of the DRD2 antagonist ONC201 in advanced solid tumor patients with weekly oral administration
19. Safety and antitumor activity of the anti–PD-1 antibody pembrolizumab in patients with advanced, PD-L1–positive papillary or follicular thyroid cancer
20. A phase I dose-escalation study of the safety and pharmacokinetics of a tablet formulation of voxtalisib, a phosphoinositide 3-kinase inhibitor, in patients with solid tumors
21. Perspectives in melanoma: Meeting report from the Melanoma Bridge (30 November–2 December, 2017, Naples, Italy)
22. An update on the Society for Immunotherapy of Cancer consensus statement on tumor immunotherapy for the treatment of cutaneous melanoma: version 2.0
23. Author Correction: Autophagy maintains tumour growth through circulating arginine
24. When Benign Tumors Mimic Malignancies: A Case of Lymphangiomatosis Masquerading as Metastatic Disease
25. Driver Mutations in Melanoma: Lessons Learned From Bench-to-Bedside Studies
26. Phase I study of gemcitabine, docetaxel and imatinib in refractory and relapsed solid tumors
27. Oncolytic Virus Immunotherapy for Melanoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.